Gene · 4646
Papers1,778
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 1,778
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Plastin-3 is a diagnostic and prognostic marker for pancreatic adenocarcinoma and distinguishes from diffuse large B-cell lymphoma. | Cancer Cell Int | 2021 | 34348730 | PubTator, text mining | PubMed |
| Rlf-Mycl Gene Fusion Drives Tumorigenesis and Metastasis in a Mouse Model of Small Cell Lung Cancer. | Cancer Discov | 2021 | 34344693 | PubTator, text mining | PubMed |
| LncRNA CCAT1 promotes prostate cancer cells proliferation, migration, and invasion through regulation of miR-490-3p/FRAT1 axis. | Aging (Albany NY) | 2021 | 34319909 | PubTator, text mining | PubMed |
| A novel class of inhibitors that target SRSF10 and promote p53-mediated cytotoxicity on human colorectal cancer cells. | NAR Cancer | 2021 | 34316707 | PubTator, text mining | PubMed |
| Mapping the molecular basis for growth related phenotypes in industrial producer CHO cell lines using differential proteomic analysis. | BMC Biotechnol | 2021 | 34301236 | PubTator, text mining | PubMed |
| Comparative Proteomic Analysis of Polarized Human THP-1 and Mouse RAW264.7 Macrophages. | Front Immunol | 2021 | 34267761 | PubTator, text mining | PubMed |
| LncRNA UCA1 promotes development of gastric cancer via the miR-145/MYO6 axis. | Cell Mol Biol Lett | 2021 | 34238213 | PubTator, text mining | PubMed |
| MicroRNA miR-145-5p inhibits Phospholipase D 5 (PLD5) to downregulate cell proliferation and metastasis to mitigate prostate cancer. | Bioengineered | 2021 | 34238129 | PubTator, text mining | PubMed |
| A dynamic Dab2 keeps myosin VI stably on track. | J Biol Chem | 2021 | 34237899 | PubTator, text mining | PubMed |
| Ephrin-A3 is required for tonotopic map precision and auditory functions in the mouse auditory brainstem. | J Comp Neurol | 2021 | 34235739 | PubTator, text mining | PubMed |
| CircCSNK1G1 Contributes to the Tumorigenesis of Gastric Cancer by Sponging miR-758 and Regulating ZNF217 Expression. | Cancer Manag Res | 2021 | 34234548 | PubTator, text mining | PubMed |
| Disease-specific ACMG/AMP guidelines improve sequence variant interpretation for hearing loss. | Genet Med | 2021 | 34230634 | PubTator, text mining | PubMed |
| Targeted Next-Generation Sequencing of Circulating Tumor DNA Mutations among Metastatic Breast Cancer Patients. | Curr Oncol | 2021 | 34202466 | PubTator, text mining | PubMed |
| Chidamide and Radiotherapy Synergistically Induce Cell Apoptosis and Suppress Tumor Growth and Cancer Stemness by Regulating the MiR-375-EIF4G3 Axis in Lung Squamous Cell Carcinomas. | J Oncol | 2021 | 34194495 | PubTator, text mining | PubMed |
| Roles of circular RNAs in colorectal cancer. | Oncol Lett | 2021 | 34188704 | PubTator, text mining | PubMed |
| Alternatives for the worse: Molecular insights into adverse effects of bisphenol a and substitutes during human adipocyte differentiation. | Environ Int | 2021 | 34186270 | PubTator, text mining | PubMed |
| A Tale of Loops and Tails: The Role of Intrinsically Disordered Protein Regions in R-Loop Recognition and Phase Separation. | Front Mol Biosci | 2021 | 34179096 | PubTator, text mining | PubMed |
| Coupling of Cell Surface Biotinylation and SILAC-Based Quantitative Proteomics Identified Myoferlin as a Potential Therapeutic Target for Nasopharyngeal Carcinoma Metastasis. | Front Cell Dev Biol | 2021 | 34178975 | PubTator, text mining | PubMed |
| The predictive prognostic values of CBFA2T3, STX3, DENR, EGLN1, FUT4, and PCDH7 in lung cancer. | Ann Transl Med | 2021 | 34164477 | PubTator, text mining | PubMed |
| A mutation of EYA1 gene in a Chinese Han family with Branchio-Oto syndrome. | Medicine (Baltimore) | 2021 | 34160378 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4646/papers?page=24